indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

All About Artificial Regenerative Skin

IMT News Desk
Incidence of accidental skin burns are increasing across the globe. Life threatening skin injuries, traumas, and burns require immediate surgical procedure to restore skin and avoid future complications. Skin burns are broadly classified into three levels, namely 1st, 2nd, and 3rd degree burns. In third degree of burns where there is little or no intact skin, artificial skin graft is the most useful treatment option. Artificial skin covers and protects the wound and also promotes regeneration of natural skin. Artificial skin is usually prepared from collagen, which is easily resorbed by the body and facilitates generation of new skin on the affected area. According to the American Burn Association, 486,000 people received medical treatment for minor burns and 70,000 people were hospitalized for severe skin burn requiring acute care in the U.S, in 2015. Various players in the market are carrying R&D activities to develop new technology related to artificial skin regeneration. One such instance is an autologous spray on skin, Recell, by Avita Medical. Artificial Skin Treatments Various skin repair devices are available, which are used to heal the affected part. These include Dermagraft, OrCel, Integra, Biobrane, Apligraft, Matriderm, Hyalomatrix, Renoskin, and Composite Cultured Skin. Dermagraft is used to help in wound closure of diabetic foot ulcers. Orcel is used to cover and aid in wound healing.  Composite Cultured Skin also contains living cells and is specifically used in children with recessive dystrophic epidermolysis bullosa. Integra is used for treatment of severe burns. On the basis of material type, the regenerative artificial skin market is segmented into temporary skin material, permanent skin material, and composite skin material. Temporary skin material: Its effect lasts between several months and 2.5 years, depending on the type, quality, and quantity of injected material. Permanent skin material: These are epidermal skin and dermal skin materials. Bio-Alcamid is a synthetic polymer that contains 97% water. It is injected into the inner tissue to fill and thicken it. Composite Skin Material: These are further sub-segmented into skin graft and engineered skin material. Some of the key players in the global regenerative artificial skin market are Integra Life Sciences Corporation, Mylan N.V., Johnson & Johnson Services, Inc. Smith & Nephew and Mallinckrodt plc. Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Recommended

India Rejects UK’s Data Exclusivity Demand to Protect Generic Drug Sector

Morepen Board proposes dividend after 23 years

Kenvue, IAP Delhi highlight effectiveness of colloidal oatmeal in skincare

BorderPlus commits Rs 10 crore in scholarships for Indian nurses

Aakash Healthcare organises CME event on paediatric nephrology

India Nears SDG 2030 Targets with Significant Drop in Maternal and Child Mortality

Dr Reddy’s posts consolidated revenue of Rs 85.1 bn in Q4 Fy25

Dr. Reddy’s Sets Sights on Top Five: A Bold Push in the Indian Market

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions